ArticleVirology journal2009
Expression and characterization of the UL31 protein from duck enteritis virus.
Article in Virology journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 34 citations in OpenAlex.
- Duck enteritis virus pUL47, as a late structural protein localized in the nucleus, mainly depends on residues 40 to 50 and 768 to 777 and inhibits IFN-β signalling by interacting with STAT1.Veterinary research · 2020Article
- Programmed cell death: the battlefield between the host and alpha-herpesviruses and a potential avenue for cancer treatment.Oncotarget · 2018Review
- Molecular characterization of duck enteritis virus UL41 protein.Virology journal · 2018Article
- Replication kinetics of duck enteritis virus UL16 gene in vitro.Virology journal · 2012Article
- Characterization of the duck enteritis virus UL55 protein.Virology journal · 2011Article
- Expression and characterization of duck enteritis virus gI gene.Virology journal · 2011Article
- Characterization of duck enteritis virus UL53 gene and glycoprotein K.Virology journal · 2011Article
- Expression and characterization of recombinant VP19c protein and N-terminal from duck enteritis virus.Virology journal · 2011Article
- Immunofluorescence analysis of duck plague virus gE protein on DPV-infected ducks.Virology journal · 2011Article
- A novel protein-coding ORF72.2 gene was identified from Marek's disease virus strain CVI988.Virology journal · 2010Article
- Identification and characterization of duck plague virus glycoprotein C gene and gene product.Virology journal · 2010Article
- Production, purification and characterization of polyclonal antibody against the truncated gK of the duck enteritis virus.Virology journal · 2010Article
- Transcription phase, protein characteristics of DEV UL45 and prokaryotic expression, antibody preparation of the UL45 des-transmembrane domain.Virology journal · 2010Article
- Expressing gK gene of duck enteritis virus guided by bioinformatics and its applied prospect in diagnosis.Virology journal · 2010Article
- Expression and intracellular localization of duck enteritis virus pUL38 protein.Virology journal · 2010Article
- Cloning, expression and characterization of gE protein of duck plague virus.Virology journal · 2010Article
- Molecular cloning and characterization of the UL31 gene from duck enteritis virus.Molecular biology reports · 2010Article
- Characterization of subcellular localization of duck enteritis virus UL51 protein.Virology journal · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies indicate that the UL31 protein and its homology play similar roles in nuclear egress of all herpesviruses. However, there is no report on the UL31 gene product of DEV. In this study, we expressed and presented the basic properties of the DEV UL31 product.
resultsThe entire ORF of the UL31 was cloned into pET 32a (+) prokaryotic expression vector. Escherichia coli BL21(DE3) competent cells were transformed with the construct followed by the induction of protein expression by the addition of IPTG. Band corresponding to the predicted sizes (55 kDa) was produced on the SDS-PAGE. Over expressed 6xHis-UL31 fusion protein was purified by nickel affinity chromatography. The DEV UL31 gene product has been identified by using a rabbit polyclonal antiserum raised against the purified protein. A protein of approximate 35 kDa that reacted with the antiserum was detected in immunoblots of DEV-infected cellular lysates, suggesting that the 35 kDa protein was the primary translation product of the UL31 gene. RT-PCR analyses revealed that the UL31 gene was transcribed most abundantly during the late phase of replication. Subsequently, Immunofluorescence analysis revealed that the protein was widespread speckled structures in the nuclei of infected cells. Western blotting of purified virion preparations showed that UL31 was a component of intracellular virions but was absent from mature extracellular virions. Finally, an Immunofluorescence assay was established to study the distribution of the UL31 antigen in tissues of artificially DEV infected ducks. The results showed that the UL31 antigen was primarily located in the cells of digestive organs and immunological organs.
conclusionIn this work, we present the basic properties of the DEV UL31 product. The results indicate that DEV UL31 shares many similarities with its HSV or PRV homolog UL31 and suggest that functional cross-complementation is possible between members of the Alphaherpesvirus subfamily. Furthermore, in vivo experiments with ducks infected with UL31-defective isolates of DEV will also be of importance in order to assess the possible role of the UL31 protein in viral pathogenesis. These properties of the UL31 protein provide a prerequisite for further functional analysis of this gene.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.